These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 21427581

  • 1. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
    Behrens F, Koehm M, Burkhardt H.
    Curr Opin Rheumatol; 2011 May; 23(3):282-7. PubMed ID: 21427581
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
    Singer O, Gibofsky A.
    Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
    [Abstract] [Full Text] [Related]

  • 3. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.
    Strangfeld A, Hierse F, Kekow J, von Hinueber U, Tony HP, Dockhorn R, Listing J, Zink A.
    Ann Rheum Dis; 2009 Dec; 68(12):1856-62. PubMed ID: 19126559
    [Abstract] [Full Text] [Related]

  • 4. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
    Bird P, Griffiths H, Tymms K, Nicholls D, Roberts L, Arnold M, Burnet S, de Jager J, Scott J, Zochling J, Littlejohn G.
    J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
    [Abstract] [Full Text] [Related]

  • 5. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
    Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
    [Abstract] [Full Text] [Related]

  • 6. [Rituximab treatment of rheumatoid arthritis: new evidence].
    Nasonov EL.
    Ter Arkh; 2009 Apr; 81(6):82-91. PubMed ID: 19663200
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration.
    Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U, van Riel PL, Nordström DC, Gomez-Reino J, Pavelka K, Tomsic M, Kvien TK, van Vollenhoven RF, Gabay C.
    Ann Rheum Dis; 2012 Mar; 71(3):374-7. PubMed ID: 21972242
    [Abstract] [Full Text] [Related]

  • 8. Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis.
    Salliot C, Finckh A, Katchamart W, Lu Y, Sun Y, Bombardier C, Keystone E.
    Ann Rheum Dis; 2011 Feb; 70(2):266-71. PubMed ID: 21097801
    [Abstract] [Full Text] [Related]

  • 9. Leflunomide or methotrexate for juvenile rheumatoid arthritis.
    Silverman E, Mouy R, Spiegel L, Jung LK, Saurenmann RK, Lahdenne P, Horneff G, Calvo I, Szer IS, Simpson K, Stewart JA, Strand V, Leflunomide in Juvenile Rheumatoid Arthritis (JRA) Investigator Group.
    N Engl J Med; 2005 Apr 21; 352(16):1655-66. PubMed ID: 15843668
    [Abstract] [Full Text] [Related]

  • 10. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
    Prescrire Int; 2010 Feb 21; 19(105):30-4. PubMed ID: 20455343
    [Abstract] [Full Text] [Related]

  • 11. Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis.
    Murdaca G, Spanò F, Puppo F.
    Expert Opin Drug Saf; 2013 Nov 21; 12(6):801-4. PubMed ID: 23889669
    [Abstract] [Full Text] [Related]

  • 12. [Three joints swollen, blood sedimentation increased. Methotrexate to be given immediately?].
    Burmester GR.
    MMW Fortschr Med; 2004 Sep 09; 146(37):10. PubMed ID: 15887693
    [No Abstract] [Full Text] [Related]

  • 13. Leflunomide.
    Cannon GW, Kremer JM.
    Rheum Dis Clin North Am; 2004 May 09; 30(2):295-309, vi. PubMed ID: 15172042
    [Abstract] [Full Text] [Related]

  • 14. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.
    Silverman E, Spiegel L, Hawkins D, Petty R, Goldsmith D, Schanberg L, Duffy C, Howard P, Strand V.
    Arthritis Rheum; 2005 Feb 09; 52(2):554-62. PubMed ID: 15693001
    [Abstract] [Full Text] [Related]

  • 15. Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis.
    Kitahara K, Kawai S.
    Curr Opin Rheumatol; 2007 May 09; 19(3):238-45. PubMed ID: 17414949
    [Abstract] [Full Text] [Related]

  • 16. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
    Flendrie M, Creemers MC, Welsing PM, van Riel PL.
    Rheumatology (Oxford); 2005 Apr 09; 44(4):472-8. PubMed ID: 15598707
    [Abstract] [Full Text] [Related]

  • 17. An update on methotrexate.
    Braun J, Rau R.
    Curr Opin Rheumatol; 2009 May 09; 21(3):216-23. PubMed ID: 19373092
    [Abstract] [Full Text] [Related]

  • 18. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A, Gross WL.
    Dtsch Med Wochenschr; 2003 Jan 24; 128(4):147-9. PubMed ID: 12589584
    [No Abstract] [Full Text] [Related]

  • 19. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C, Chen S, Gu Y, Lao Z, Ni L, Yu Q, Xu J, Li X, Liu J, Sun L, He P, Ma J, Xu S, Ding C.
    Chin Med J (Engl); 2003 Aug 24; 116(8):1228-34. PubMed ID: 12935395
    [Abstract] [Full Text] [Related]

  • 20. The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapy.
    Smolen JS, Emery P, Kalden JR, Van Riel PL, Dougados M, Strand CV, Breedveld FC.
    J Rheumatol Suppl; 2004 Jun 24; 71():13-20. PubMed ID: 15170903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.